REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,712,748 | +228.8% | 26,606 | -15.0% | 0.01% | +350.0% |
| Q4 2021 | $825,000 | -68.2% | 31,294 | +21.4% | 0.00% | -75.0% |
| Q3 2021 | $2,594,000 | -38.9% | 25,784 | -14.0% | 0.01% | -42.9% |
| Q2 2021 | $4,244,000 | +114.0% | 29,988 | +50.8% | 0.01% | +100.0% |
| Q1 2021 | $1,983,000 | -15.2% | 19,890 | +5.2% | 0.01% | -12.5% |
| Q4 2020 | $2,338,000 | +10.9% | 18,915 | -12.6% | 0.01% | 0.0% |
| Q3 2020 | $2,109,000 | -18.7% | 21,647 | +30.2% | 0.01% | -27.3% |
| Q2 2020 | $2,594,000 | +24.2% | 16,625 | +14.9% | 0.01% | +10.0% |
| Q1 2020 | $2,089,000 | -29.4% | 14,474 | 0.0% | 0.01% | -9.1% |
| Q4 2019 | $2,959,000 | – | 14,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $110,053,269 | 27.64% |
| Ghost Tree Capital, LLC | 500,000 | $18,995,000 | 8.11% |
| First Light Asset Management, LLC | 2,062,453 | $78,352,589 | 7.27% |
| Boxer Capital, LLC | 1,230,004 | $46,727,852 | 2.46% |
| Sofinnova Investments, Inc. | 992,029 | $37,687,182 | 2.24% |
| Tri Locum Partners LP | 141,466 | $5,374,000 | 2.17% |
| MPM BioImpact LLC | 194,181 | $7,376,936 | 1.91% |
| Ikarian Capital, LLC | 201,200 | $7,643,588 | 1.84% |
| KRS Capital Management, LLC | 28,141 | $1,069,077 | 1.46% |
| EMERALD ADVISERS, LLC | 679,772 | $25,824,538 | 1.25% |